These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 26696553)
1. Carcinogenic Chromium(VI) Compounds Formed by Intracellular Oxidation of Chromium(III) Dietary Supplements by Adipocytes. Wu LE; Levina A; Harris HH; Cai Z; Lai B; Vogt S; James DE; Lay PA Angew Chem Int Ed Engl; 2016 Jan; 55(5):1742-5. PubMed ID: 26696553 [TBL] [Abstract][Full Text] [Related]
2. Reactivity of chromium(III) nutritional supplements in biological media: an X-ray absorption spectroscopic study. Nguyen A; Mulyani I; Levina A; Lay PA Inorg Chem; 2008 May; 47(10):4299-309. PubMed ID: 18433095 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of a chromium(V) cis-dioxo bis(1,10-phenanthroline) complex and crystal and molecular structures of its chromium(III) precursor. Weeks CL; Levina A; Dillon CT; Turner P; Fenton RR; Lay PA Inorg Chem; 2004 Nov; 43(24):7844-56. PubMed ID: 15554650 [TBL] [Abstract][Full Text] [Related]
4. Formation and reactivity of chromium(V)-thiolato complexes: a model for the intracellular reactions of carcinogenic chromium(VI) with biological thiols. Levina A; Zhang L; Lay PA J Am Chem Soc; 2010 Jun; 132(25):8720-31. PubMed ID: 20527748 [TBL] [Abstract][Full Text] [Related]
5. X-ray absorption and EPR spectroscopic studies of the biotransformations of chromium(VI) in mammalian cells. Is chromodulin an artifact of isolation methods? Levina A; Harris HH; Lay PA J Am Chem Soc; 2007 Feb; 129(5):1065-75. PubMed ID: 17263387 [TBL] [Abstract][Full Text] [Related]
6. Spectroscopic characterization of genotoxic chromium(V) peptide complexes: Oxidation of Chromium(III) triglycine, tetraglycine and pentaglycine complexes. Headlam HA; Lay PA J Inorg Biochem; 2016 Sep; 162():227-237. PubMed ID: 27365280 [TBL] [Abstract][Full Text] [Related]
7. X-ray absorption near edge structure and extended X-ray absorption fine structure analysis of standards and biological samples containing mixed oxidation states of chromium(III) and chromium(VI). Parsons JG; Dokken K; Peralta-Videa JR; Romero-Gonzalez J; Gardea-Torresdey JL Appl Spectrosc; 2007 Mar; 61(3):338-45. PubMed ID: 17389076 [TBL] [Abstract][Full Text] [Related]
8. Time-dependent uptake, distribution and biotransformation of chromium(VI) in individual and bulk human lung cells: application of synchrotron radiation techniques. Harris HH; Levina A; Dillon CT; Mulyani I; Lai B; Cai Z; Lay PA J Biol Inorg Chem; 2005 Mar; 10(2):105-18. PubMed ID: 15714299 [TBL] [Abstract][Full Text] [Related]
9. The effects of hydraulic retention time (HRT) on chromium(VI) reduction using autotrophic cultivation of Chlorella vulgaris. Lee L; Hsu CY; Yen HW Bioprocess Biosyst Eng; 2017 Dec; 40(12):1725-1731. PubMed ID: 28871394 [TBL] [Abstract][Full Text] [Related]
10. Comparative histological studies on liver of mice exposed to Cr(VI) and Cr(V) compounds. das Neves RP; Santos TM; Pereira Mde L; de Jesus JP Hum Exp Toxicol; 2002 Jul; 21(7):365-9. PubMed ID: 12269698 [TBL] [Abstract][Full Text] [Related]
11. Isolation, characterization, and nuclease activity of biologically relevant chromium(V) complexes with monosaccharides and model diols. Likely intermediates in chromium-induced cancers. Bartholomäus R; Irwin JA; Shi L; Smith SM; Levina A; Lay PA Inorg Chem; 2013 Apr; 52(8):4282-92. PubMed ID: 23531300 [TBL] [Abstract][Full Text] [Related]
12. Chemical properties and toxicity of chromium(III) nutritional supplements. Levina A; Lay PA Chem Res Toxicol; 2008 Mar; 21(3):563-71. PubMed ID: 18237145 [TBL] [Abstract][Full Text] [Related]
13. Solution structures of chromium(VI) complexes with glutathione and model thiols. Levina A; Lay PA Inorg Chem; 2004 Jan; 43(1):324-35. PubMed ID: 14704084 [TBL] [Abstract][Full Text] [Related]
14. Reduction and immobilization of chromium(VI) by iron(II)-treated faujasite. Kiser JR; Manning BA J Hazard Mater; 2010 Feb; 174(1-3):167-74. PubMed ID: 19796874 [TBL] [Abstract][Full Text] [Related]
15. Chromium oxidation state imaging in mammalian cells exposed in vitro to soluble or particulate chromate compounds. Ortega R; Fayard B; Salomé M; Devès G; Susini J Chem Res Toxicol; 2005 Oct; 18(10):1512-9. PubMed ID: 16533014 [TBL] [Abstract][Full Text] [Related]
16. Oxochromium(V) species formed with 2,3-dehydro-2-deoxy-N-acetylneuraminic or N-acetylneuraminic (sialic) acids: an in vitro model system of oxochromium(V) species potentially stabilized in the respiratory tract upon inhalation of carcinogenic chromium(VI) compounds. Codd R; Lay PA Chem Res Toxicol; 2003 Jul; 16(7):881-92. PubMed ID: 12870891 [TBL] [Abstract][Full Text] [Related]
17. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach. Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082 [TBL] [Abstract][Full Text] [Related]
18. A novel strategy for Cr(III) and Cr(VI) analysis in dietary supplements by speciated isotope dilution mass spectrometry. Unceta N; Astorkia M; Abrego Z; Gómez-Caballero A; Goicolea MA; Barrio RJ Talanta; 2016 Jul; 154():255-62. PubMed ID: 27154672 [TBL] [Abstract][Full Text] [Related]
19. Cr(VI) reduction by a potent novel alkaliphilic halotolerant strain Pseudochrobactrum saccharolyticum LY10. Long D; Tang X; Cai K; Chen G; Chen L; Duan D; Zhu J; Chen Y J Hazard Mater; 2013 Jul; 256-257():24-32. PubMed ID: 23669787 [TBL] [Abstract][Full Text] [Related]
20. Carcinogenic chromium(VI)-induced protein oxidation and lipid peroxidation: implications in DNA-protein crosslinking. Mattagajasingh SN; Misra BR; Misra HP J Appl Toxicol; 2008 Nov; 28(8):987-97. PubMed ID: 18615841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]